OMNIlife science, Inc. (also known as "OMNI"), an established medical technology company targeting the $15 billion and rapidly growing global hip and knee replacement medical device sector, announces the closing of a  $27.5 million debt financing. The debt facility is being provided by affiliates of Deerfield Management Company. OMNI is an established hip and knee implant replacement engineering, manufacturing and distribution company that has also developed a Robotics and Navigation platform, called OMNInav™, which uses a proprietary computer-assisted robotic cutting guide technology called "OMNIplasty™."

OMNI plans to use the proceeds of the financing to continue expansion of its already extensive hip and knee replacement implant product lines and to complete commercial development of its proprietary FDA cleared OMNInav hip replacement solution. OMNI also plans to more than double the number of deployed OMNInav systems from 18 at the time of this announcement to 50 by the end of 2015, while replacing all of the current first-generation OMNInav units with new second-generation OMNInav stations and software.

OMNIplasty is currently the only orthopedic robotic navigation solution that is FDA cleared and readily available to address primary total knee replacement. Primary total knee replacement represents over 80 percent of all knee replacement surgery performed today. Other available robotic systems currently only address partial knee replacement, which represents less than 10 percent of the global knee replacement surgery market. To date, over 3,000 OMNIplasty procedures have been performed in the U.S. and international markets.

"Deerfield has been an active investor in robotic systems designed to aid in surgical procedures.  OMNIlife science has developed a cost-effective computer navigation and robotic platform in orthopedics for improved outcomes of total joint replacement procedures," stated Steve Hochberg, a Partner at Deerfield Management.

Aquilo Partners, L.P., a life science investment bank, acted as the exclusive placement agent for the financing.

Deerfield is an investment management firm, committed to advancing healthcare through investment, information and philanthropy.

OMNI is an established hip and knee implant replacement engineering, manufacturing and distribution company that has also developed a proprietary Robotics and Navigation platform, called OMNInav™, that uses proprietary computer-assisted robotic cutting guide technology, or "OMNIplasty.